CSWYY (China Shineway Pharmaceutical Group) Cash Flow from Others: $31.7 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
87 GF Score
Price $19.25
GF Value $16.05
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Cash Flow from Others?

China Shineway Pharmaceutical Group CSWYY 87 Cash Flow from Others is $31.7 Mil as of Dec. 2025. GuruFocus rates CSWYY with a GF Score™ of 87/100 and a GF Value™ of $16.05. The stock has 2 warning signs investors should review.

China Shineway Pharmaceutical Group's cash flow from others for the six months ended in Dec. 2025 was $38.4 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2025 was $31.7 Mil.

China Shineway Pharmaceutical Group Cash Flow from Others Related Terms

China Shineway Pharmaceutical Group Cash Flow from Others Historical Data

* Premium members only.

The historical data trend for China Shineway Pharmaceutical Group's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group Cash Flow from Others Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.09 -40.61 -54.78 -65.01 -95.22

China Shineway Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.66 -8.60 25.47 -6.73 38.40
CSWYY
87GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
Cash Flow from Others is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Shineway Pharmaceutical Group Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $31.7 Mil.

Frequently Asked Questions Learn more about Cash Flow from Others →
What does a Cash Flow from Others of $31.7 Mil mean?
China Shineway Pharmaceutical Group (CSWYY) has a Cash Flow from Others of $31.7 Mil as of Dec. 2025. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for China Shineway Pharmaceutical Group and its competitors.
Is China Shineway Pharmaceutical Group's Cash Flow from Others too high?
China Shineway Pharmaceutical Group's current Cash Flow from Others is $31.7 Mil. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Cash Flow from Others compare to ZTS?
China Shineway Pharmaceutical Group's Cash Flow from Others of $31.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Others for a Drug Manufacturers company?
A good Cash Flow from Others depends on the Drug Manufacturers industry context. However, Cash Flow from Others should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Others mean?
A high Cash Flow from Others can signal that a stock is expensive relative to its fundamentals. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current Cash Flow from Others is $31.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current Cash Flow from Others of $31.7 Mil. The stock's GF Value™ is $16.05, compared to a current price of $19.25 — trading 19.9% above its estimated fair value. The current Cash Flow from Others is $31.7 Mil. China Shineway Pharmaceutical Group's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Others calculated?
Cash Flow from Others is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current Cash Flow from Others is $31.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 19.9% above its estimated GF Value™ of $16.05.

Key valuation signals for CSWYY:

  • Cash Flow from Others: $31.7 Mil
  • GF Value™: $16.05 vs. price of $19.25 (19.9% above fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
87GF Score

Get the complete analysis for CSWYY

Cash Flow from Others is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$16.05
GF Value